Drug
Icotinib hydrochloride clinical trials
Also written Conmana.
A product of Icotinib; its studies count on that page too.
- studies test it
- 6
- open now
- 0
- in phase 3
- 0
- first study started
- 2013
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2016 (2)
| Year | Studies |
|---|---|
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 3
Betta Pharmaceuticals Co., Ltd. (3) · Yuhong Li (1) · Henan Provincial People's Hospital (1) · Roswell Park Cancer Institute (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses icotinib hydrochloride is read from its arms, and is right about nine times in ten.
Testing it · 6
- Study of Icotinib Hydrochloride in Treating Patients With Recurrent or Metastatic Esophageal Cancer After Failure of Conventional ChemotherapyCompletedPhase 2Yuhong LiNCT01973725Written as Icotinib Hydrochloride
- Study of Icotinib Hydrochloride Cream in Patients With Mild to Moderate PsoriasisTerminatedPhase 2Betta Pharmaceuticals Co., Ltd.NCT03222622Written as Icotinib hydrochloride cream
- Icotinib Hydrochloride Cream in Patients With Mild to Moderate PsoriasisCompletedPhase 1Betta Pharmaceuticals Co., Ltd.NCT02801435Written as 0.5% Icotinib hydrochloride cream
- Icotinib Hydrochloride Cream in Healthy Adults and Psoriasis PatientsCompletedPhase 1Betta Pharmaceuticals Co., Ltd.NCT02574091Written as 1% icotinib hydrochloride cream
- Conmana Combined With Thalidomide to Treat NSCLCStatus unknownPhase 4Henan Provincial People's HospitalNCT02778893Written as Conmana
- Icotinib Hydrochloride in Treating Patients With Advanced CancersWithdrawnPhase 1Roswell Park Cancer InstituteNCT02033148Written as icotinib hydrochloride
As the comparator · 2 — what is tested is compared with icotinib hydrochloride
- D-0316 Versus Icotinib in Patients With Locally Advanced or Metastatic EGFR Sensitising Mutation Positive NSCLCCompletedPhase 2/3Betta Pharmaceuticals Co., Ltd.NCT04206072Written as Icotinib Hydrochloride Tablets
- Icotinib at Different Doses in Second-line Treatment for Non-small Cell Lung Cancer Patients With Wild Type EGFRStatus unknownPhase 2Tianjin Medical University Cancer Institute and HospitalNCT01744925Written as Icotinib of routine dose
Codes
What other systems call icotinib hydrochloride · ClinicalTrials.gg INT016980
- UNII (FDA) JTD32I0J83ICOTINIB HYDROCHLORIDEConfirmed FDA, Wikidata
- Wikidata Q27281690icotinib hydrochlorideConfirmed FDA, Wikidata
- NCI Thesaurus C99160Icotinib HydrochlorideOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | JTD32I0J83 | ICOTINIB HYDROCHLORIDE | Confirmed FDA, Wikidata |
| Wikidata | Q27281690 | icotinib hydrochloride | Confirmed FDA, Wikidata |
| NCI Thesaurus | C99160 | Icotinib Hydrochloride | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.